Spironolactone and cardiac failure congestive Patient Reports February 11, 2012
Spironolactone Side Effects Report #4608411-6
Spironolactone side effect was reported by a Pharmacist from on Mar 11, 2005. Male patient, 78 years of age, weighting 145.3 lb, was diagnosed with hyperkalaemia and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, hyperkalaemia. Spironolactone dosage: 25 MG PO QD. During the same period patient was treated with KCL, LISINOPRIL. Patient was hospitalized. Patient recovered.
Spironolactone Side Effects Report #5017585-7
Spironolactone side effect was reported by a Physician from UNITED STATES on June 01, 2006. Female patient, 85 years of age, weighting 138.0 lb, was diagnosed with cardiac failure congestive, hypokalaemia and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac failure congestive, dyspnoea. Spironolactone dosage: 100 MG PO DAILY MONTHS. During the same period patient was treated with RYTHMOL, PREMARIN, WARFARIN, LASIX, PREDNISONE, GLYPAZIDE, QUININE SULPHATE. Patient was hospitalized. Patient recovered.Spironolactone Side Effects Report #4543825-4
Spironolactone side effect was reported by a Consumer or non-health professional from on Sept 15, 2003. Male patient, 67 years of age, was diagnosed with cardiac failure congestive and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: blood creatinine increased, cardiac arrest
, cardiac failure congestive, condition aggravated, contraindication to medical treatment, heart rate decreased, hyperkalaemia. Spironolactone dosage: 25 MG, QD, ORAL. During the same period patient was treated with ENALAPRIL. Patient was hospitalized. Patient died.Spironolactone Side Effects Report #5643711-2
Spironolactone side effect was reported by a Health Professional from UNITED KINGDOM on Feb 18, 2008. Male patient, 65 years of age, was diagnosed with cardiac failure congestive, schizophrenia and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dyspnoea, fall
. Spironolactone dosage: unknown. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient recovered.Spironolactone Side Effects Report #4907310-X
Spironolactone side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2006. Male patient, 65 years of age, weighting 297.6 lb, was diagnosed with cardiac failure congestive, blood potassium decreased and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, dizziness
, hyperkalaemia. Spironolactone dosage: 25 MG 4TABS/DAY ORAL. During the same period patient was treated with POTASSIUM CHLORIDE, LISINOPRIL, LOSARTAN POTASSIUM, DILTIAZEM. Patient was hospitalized. Patient recovered.Spironolactone Side Effects Report #5945791-3
Spironolactone side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2008. Male patient, 59 years of age, was diagnosed with cardiac failure congestive and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, hepatic congestion. Spironolactone dosage: 25 MG; BID; PO. During the same period patient was treated with LASIX, DIGITEK, ALTACE, COREG, ASPIRIN. Patient was hospitalized. Patient recovered.
Spironolactone Side Effects Report #4583807-X
Spironolactone side effect was reported by a Consumer or non-health professional from on Dec 23, 2004. Male patient, 67 years of age, was diagnosed with cardiac failure and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: blood creatinine increased, cardiac arrest
, cardiac failure congestive, glomerular filtration rate decreased, heart rate decreased, hyperkalaemia. Spironolactone dosage: 25 MG DAILY ORAL. During the same period patient was treated with ENALAPRIL MALEATE. Patient was hospitalized. Patient died.Spironolactone Side Effects Report #4987498-5
Spironolactone side effect was reported by a Physician from UNITED STATES on Dec 15, 2005. Female patient, 53 years of age, weighting 134.5 lb, was diagnosed with arthritis
and was treated with Spironolactone. After drug was administered, patient experienced the following side effects: angina unstable, angiopathy, cardiac arrest
, cardiac disorder, cardiac failure congestive, carotid artery disease
, cerebrovascular accident, chronic obstructive pulmonary disease, convulsion. Spironolactone dosage: unknown. During the same period patient was treated with VIOXX, ADVAIR DISKUS, AMITRIPTYLINE HYDROCHLORIDE, DARVOCET, NEURONTIN, METOPROLOL, ESTRADIOL. Patient was hospitalized. Patient recovered.
Spironolactone and cardiac failure congestive 